resectable NSCLC
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
July, 2024
July 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Jun
resectable NSCLC
Jun 29, 2024, 14:04 |
Insight
Piotr Wysocki: Combination of nivolumab and relatlimab in neoadjuvant setting in resectable NSCLC
Piotr Wysocki recently posted on LinkedIn: "Martin Schuler et al. published results of their phase 2…
May 28, 2024, 07:48 |
Insight
Full results and Plain Language Summary for CheckMate 77T trial - NEJM
NEJM shared on X/Twitter: "In the CheckMate 77T trial, researchers assessed whether adding adjuvant nivolumab to…
May 27, 2024, 07:35 |
Blog
Check out the state of immunotherapy in resectable NSCLC - FDA Oncology
FDA Oncology shared a post on X: “Check out the state of immunotherapy in resectable NSCLC:…
May 1, 2024, 09:08 |
Insight
Piotr Wysocki: Adjuvant immunotherapy in NSCLC patients who underwent radical resection preceded by immunotherapy
Piotr Wysocki recently shared on LinkedIn: "Zhou Y et al. have conducted an indirect meta-analysis…
Mar 25, 2024, 15:09 |
Insight
Jarushka Naidoo: Surgical outcomes of RATIONALE-315 (Neoadjuvant Tis + chemo in resectable NSCLC)
Jarushka Naidoo recently posted on X: "Surgical outcomes of RATIONALE-315 (Neoadjuvant Tis+chemo in resectable NSCLC): -…
All:
5
Posts:
1 - 100
OncoDaily at ASCO 2024: OncoDaily Party, Yvonne Award and much more
Tedros Adhanom Ghebreyesus received University of Nicosia’s Honorary Doctorate
Lisa A. Lacasse: A major milestone towards Congress passing the bipartisan MCED Act
July is Sarcoma Awareness Month
25 Posts You Should Not Miss From ESMOGI24!
Facebook
RSS Feed
Twitter
Linkedin
Youtube